- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 33/10 - Anthelmintics
Patent holdings for IPC class A61P 33/10
Total number of patents in this class: 486
10-year publication summary
|
16
|
14
|
23
|
33
|
25
|
36
|
26
|
31
|
24
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Intervet International B.V. | 1301 |
28 |
| Bayer Animal Health GmbH | 216 |
22 |
| Elanco Tiergesundheit AG | 416 |
22 |
| Elanco Animal Health GmbH | 338 |
18 |
| Intervet Inc. | 905 |
17 |
| Nihon Nohyaku Co., Ltd. | 329 |
16 |
| Nippon Soda Co., Ltd. | 889 |
14 |
| University of Massachusetts | 2263 |
13 |
| Boehringer Ingelheim Animal Health USA Inc. | 420 |
12 |
| The Governing Council of The University of Toronto, | 1509 |
11 |
| Boehringer Ingelheim Vetmedica GmbH | 1278 |
9 |
| CEVA Sante Animale | 702 |
9 |
| Sumitomo Chemical Company, Limited | 9106 |
8 |
| Zoetis LLC | 46 |
8 |
| Celgene Corporation | 1397 |
7 |
| The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. | 379 |
5 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2918 |
5 |
| The University of Tokyo | 4262 |
5 |
| Bomac Research Limited | 14 |
5 |
| Nissan Chemical Corporation | 2118 |
5 |
| Other owners | 247 |